BeStock  
Stocks › Medical Devices › IRMD

IRadimed IRMD

US equityMarket cap rank #3131Medical Devices
$81.02 −$0.24 (-0.30%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $81.02 0.00%
Open$80.61
Prev close$81.26
Day range$80.61 – $82.11
Volume101.3K
Market cap$1.04B
P/E (TTM)43.3
Dividend yield0.95%

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$24.20M+14.2% YoY
Operating profit$8.14M+19.1% YoY
Net profit$6.51M+16.7% YoY
Diluted EPS$0.51+18.6% YoY
Free cash flow$6.79M+18.6% YoY
Operating cash flow$7.00M

Revenue, last 8 quarters

$19.4MDec '24$19.5MMar '25$20.4MJun '25$21.2MSep '25$22.7MDec '25$22.0MMar '26$20.5MJun '26$24.2MSep '26

Net profit, last 8 quarters

$5.1MDec '24$4.7MMar '25$5.8MJun '25$5.6MSep '25$6.4MDec '25$5.8MMar '26$5.2MJun '26$6.5MSep '26

Diluted EPS by quarter

0.40Dec '240.37Mar '250.45Jun '250.43Sep '250.50Dec '250.45Mar '260.41Jun '260.51Sep '26

Free cash flow by quarter

$2.9MDec '24$375.0KMar '25$4.9MJun '25$5.7MSep '25$5.5MDec '25$7.8MMar '26$5.5MJun '26$6.8MSep '26

Annual revenue

$31.7MFY20$41.8MFY21$53.3MFY22$65.6MFY23$73.2MFY24$83.8MFY25

Profitability & balance sheet

Gross margin75.5%
Operating margin32.3%
Net margin26.8%
Return on equity23.4%
Return on assets20.3%
Return on invested capital23.4%
Current ratio8.99
Liabilities / assets12.1%
Cash & investments$63.29M
Net cash (debt)$63.29M
Free cash flow / sales28.7%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $24.20M $20.47M $21.98M $83.81M $22.69M
Total Operating Revenue $24.20M $20.47M $21.98M $83.81M $22.69M
Cost of Revenue $5.75M $5.31M $5.17M $19.49M $5.66M
Gross Profit $18.46M $15.16M $16.81M $64.32M $17.03M
Operating Expense $10.32M $8.77M $9.58M $38.18M $9.94M
Selling and Admin Expenses $9.44M $8.11M $8.62M $35.20M $9.14M
-Selling & Marketing Expense $4.91M $4.25M $4.05M $17.42M $4.60M
-General & Admin Expense $4.53M $3.87M $4.57M $17.78M $4.54M
Research & Development $875,000.00 $657,000.00 $956,000.00 $2.98M $799,000.00
Operating Profit $8.14M $6.39M $7.24M $26.15M $7.09M
Other Income (Expense) $529,000.00 $497,000.00 $532,000.00 $205,000.00 -$1.31M
Other Non-Operating Income (Expenses) $529,000.00 $497,000.00 $532,000.00 – –
Pretax Profit $8.67M $6.89M $7.77M $28.36M $7.79M
Tax $2.16M $1.67M $1.95M $5.88M $1.35M
Net Profit $6.51M $5.22M $5.82M $22.48M $6.44M
Profit from Continuing Operations $6.51M $5.22M $5.82M $22.48M $6.44M
Net Income to Parent Company $6.51M $5.22M $5.82M $22.48M $6.44M
Net Income to Common Stockholders $6.51M $5.22M $5.82M $22.48M $6.44M
Basic EPS $0.51 $0.41 $0.46 $1.77 $0.51
Diluted EPS $0.51 $0.41 $0.45 $1.75 $0.50
Dividend Per Share $0.20 $0.20 $0.20 $0.68 $0.17
Net Non-Operating Interest Income (Expense) – – – $2.01M –
Non-Operating Interest Income – – – $2.01M –
Gain on Sale of Security – – – $2,000.00 –
Special Income (Charges) – – – $203,000.00 –
-Gain on Sale of Property/Plant/Equipment – – – $203,000.00 –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $121.07M $114.98M $114.39M $108.78M $108.78M
Total Current Assets $92.80M $86.72M $86.42M $81.20M $81.20M
Cash and Cash Equivalents & Short-Term Investments $63.29M $59.08M $56.37M $51.16M $51.16M
-Cash and Cash Equivalents $63.29M $59.08M $56.37M $51.16M $51.16M
Receivables $13.67M $13.19M $13.42M $13.67M $13.67M
-Accounts Receivable $13.67M $13.19M $13.42M $13.67M $13.67M
Prepaid Assets $1.10M $792,000.00 $3.13M – –
Inventory $13.49M $12.26M $11.88M $11.62M $11.62M
Other Current Assets $1.25M $1.40M $1.63M $4.76M $4.76M
Total Non-Current Assets $28.27M $28.25M $27.97M $27.57M $27.57M
Net PPE $24.08M $24.21M $24.23M $23.86M $23.86M
-Gross PPE $30.05M $29.88M $29.59M $28.93M $28.93M
-Accumulated Depreciation -$5.97M -$5.67M -$5.36M -$5.07M -$5.07M
Goodwill and Other Intangible Assets $3.41M $3.44M $3.29M $3.38M $3.38M
-Other Intangible Assets $3.41M $3.44M $3.29M $3.38M $3.38M
Non-Current Deferred Assets $524,000.00 $363,000.00 $231,000.00 $94,000.00 $94,000.00
Other Non-Current Assets $258,000.00 $244,000.00 $225,000.00 $239,000.00 $239,000.00
Total Liabilities $14.62M $13.23M $15.88M $14.16M $14.16M
Total Current Liabilities $10.32M $9.16M $12.12M $10.18M $10.18M
Payables $2.97M $2.49M $6.51M $3.63M $3.63M
-Accounts Payable $2.42M $1.85M $2.18M $1.82M $1.82M
-Total Tax Payable $548,000.00 $641,000.00 $4.33M $1.81M $1.81M
Current Accrued Expenses $3.62M $3.06M $2.07M $3.22M $3.22M
Current Provisions $161,000.00 $146,000.00 $144,000.00 $144,000.00 $144,000.00
Current Deferred Liabilities $3.57M $3.47M $3.40M $2.87M $2.87M
Total Non-Current Liabilities $4.29M $4.06M $3.76M $3.98M $3.98M
Non-Current Deferred Liabilities $4.29M $4.06M $3.76M $3.98M $3.98M
Total Equity $106.45M $101.75M $98.51M $94.62M $94.62M
Stockholders' Equity $106.45M $101.75M $98.51M $94.62M $94.62M
Capital Stock $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00
-Common Stock $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00
Additional Paid-In Capital $32.35M $31.59M $31.02M $30.39M $30.39M
Retained Earnings $74.10M $70.15M $67.49M $64.23M $64.23M
Other Current Liabilities – – – $313,000.00 $313,000.00
Long Term Debt and Capital Lease Obligation – – – $0.00 $0.00
-Long Term Capital Lease Obligation – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $7.00M $5.94M $8.29M $24.95M $5.92M
Net cash flow from continuing operations $7.00M $5.94M $8.29M $24.95M $5.92M
Net Income from Continuing Operations $6.51M $5.22M $5.82M $22.48M $6.44M
Depreciation & Depletion & Amortization $412,000.00 $410,000.00 $455,000.00 $1.17M $381,000.00
Deferred Tax -$161,000.00 -$132,000.00 -$137,000.00 $2.73M $2.33M
Change in Working Capital -$671,000.00 -$344,000.00 $1.42M -$4.35M -$3.95M
-Change in Receivables -$593,000.00 $280,000.00 $212,000.00 -$3.03M $191,000.00
-Change in Inventory -$1.30M -$515,000.00 -$534,000.00 -$1.38M $54,000.00
-Change in Prepaid Assets -$158,000.00 $2.56M $7,000.00 -$2.71M -$1.96M
-Change in Payables and Accrued Expense $1.04M -$3.03M $1.41M $1.33M -$2.34M
-Change in Other Current Assets -$14,000.00 -$18,000.00 $13,000.00 -$40,000.00 -$25,000.00
-Change in Other Current Liabilities $0.00 $0.00 $0.00 -$150,000.00 $0.00
-Change In Other Working Capital $348,000.00 $380,000.00 $305,000.00 $1.62M $125,000.00
Net cash flow from investing -$212,000.00 -$443,000.00 -$469,000.00 -$8.42M -$416,000.00
Net Cash Flow from Continuing Investing Activities -$212,000.00 -$443,000.00 -$469,000.00 -$8.42M -$416,000.00
Capital Expenditure -$82,000.00 -$258,000.00 -$66,000.00 -$656,000.00 -$122,000.00
Net PPE Purchase and Sale -$130,000.00 -$185,000.00 -$403,000.00 -$7.77M -$294,000.00
Financing Cash Flow -$2.58M -$2.79M -$2.61M -$17.60M -$10.87M
Net Cash Flow from Continuing Financing Activities -$2.58M -$2.79M -$2.61M -$17.60M -$10.87M
Cash Dividends Paid -$2.56M -$2.56M -$2.56M -$15.04M -$8.55M
Net Other Financing Charges -$19,000.00 -$234,000.00 -$50,000.00 -$2.56M -$2.32M
Ending Cash Balance $63.29M $59.08M $56.37M $51.16M $51.16M
Net Change in Cash $4.21M $2.71M $5.22M -$1.08M -$5.37M
Beginning Cash Balance $59.08M $56.37M $51.16M $52.23M $56.53M
Free Cash Flow $6.79M $5.50M $7.82M $16.53M $5.51M
Gain/Loss from Continuing Operations – – – $37,000.00 $3,000.00
Proceeds from Stock Option Exercised – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on IRMD.

Sign in to join the discussion.

Scroll to Top